Earlier this month, the second annual San Diego Cardiovascular Interventions (SDCI) conference was held in La Jolla, CA. The two-day meeting focused on robotics for coronary and peripheral interventions and CHIP, or Complex High-Risk (and Indicated) Patients.
Day one of the conference focused on future innovations including the current applications for robotic therapy, primarily in PCI. Course Director, Dr. Ehtisham Mahmud performed two complex robotic-assisted PCIs that were transmitted from the UC San Diego Sulpizio Cardiovascular Center. During both interventions, Dr. Mahmud was seated behind an interventional cockpit without the need for heavy lead personal protective equipment. He was able to drive both guidewires and balloon/stent catheters using the robotics system’s joysticks and touchscreen controls.
Dr. Mahmud performing robotic-assisted PCI during a live case transmission
One of the topics that came up during the panel discussion and was discussed in further detail during the sessions was the ability to perform not only simple procedures but complex procedures using the robotic system. The CORA-PCI Trial, which was initially presented at the SCAI 2016 Scientific Sessions as a Late Breaking Clinical Trial, demonstrated that the use of the CorPath System for robotic-assisted PCI was and effective alternative to manual intervention. In addition, the study showed that in complex PCI, procedure time is equivalent to manual. This is an important point as complex procedures tend to be longer, adding to radiation exposure and time in heavy lead for cath lab teams, which robotics was designed to protect against.
Day one rounded out with a discussion of cath lab innovation and future applications for technologies. The focus of these sessions was on the question of “How can we continuously improve what we do every day for our patients and for ourselves?”
Dr. Ryan Madder discussing occupational hazards, how robotics may help
The second day of the meeting continued the theme of advances in interventional medicine with a focus on Complex and High-Risk PCI and structural interventions. Among the technologies discussed were hemodynamic support, atherectomy devices, bioresorbable stents, and TAVR devices. The common theme among these technologies and robotic therapy is that each new innovation requires a commitment from cath lab teams to building a program to support the success of these new innovations.
At Corindus, we are committed to building strong vascular robotic programs to help hospitals maximize the benefits of robotic therapy. There are several key components to building a robotic program that, if done successfully, will push your hospital ahead of the curve by offering the latest in precision medicine for your patients while at the same time, protecting the healthcare providers who devote their lives to saving others. To learn more about starting a program, download our comprehensive eBook.